We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+24.52%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$11.9B
AUM Growth
-$101M
(-0.84%)
Cap. Flow
-$1.72B
Cap. Flow
% of AUM
-14.47%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,692
New
482
Increased
315
Reduced
482
Closed
413
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$242M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$187M |
| 3 |
AstraZeneca
AZN
|
+$163M |
| 4 |
Lockheed Martin
LMT
|
+$162M |
| 5 |
S&P Global
SPGI
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$234M |
| 2 |
Johnson & Johnson
JNJ
|
+$185M |
| 3 |
Mercado Libre
MELI
|
+$136M |
| 4 |
Procter & Gamble
PG
|
+$128M |
| 5 |
Shopify
SHOP
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.38% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Industrials | 11.12% |
| 5 | Communication Services | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Prestige Consumer Healthcare
PBH
$2.42B
| $884K | 0.01% |
25,346
+19,373
| +324% | +$688K |
|
1002
Ameresco
AMRC
$1.48B
| $878K | 0.01% |
16,815
-46,606
| -73% | -$2.01M |
|
1003
AudioCodes
AUDC
$253M
| $877K | 0.01% |
+31,820
| New | +$933K |
|
1004
Dana Inc
DAN
$3.25B
| $877K | 0.01% |
44,927
+56
| +0.1% | +$937 |
|
1005
Alkermes
ALKS
$8.32B
| $876K | 0.01% |
+43,888
| New | +$803K |
|
1006
Trustmark
TRMK
$2.82B
| $871K | 0.01% |
31,900
-59,061
| -65% | -$1.48M |
|
1007
Universal Corp
UVV
$1.14B
| $871K | 0.01% |
17,922
-23,864
| -57% | -$1.07M |
|
1008
SelectQuote
SLQT
$129M
| $867K | 0.01% |
+41,787
| New | +$858K |
|
|
SWTX
1009
DELISTED
SpringWorks Therapeutics
SWTX
| $867K | 0.01% |
+11,957
| New | +$770K |
|
1010
St. Joe Company
JOE
$3.91B
| $866K | 0.01% |
+20,396
| New | +$649K |
|
1011
Melco Resorts & Entertainment
MLCO
$2.14B
| $866K | 0.01% |
+46,673
| New | +$812K |
|
1012
Petrobras Class A
PBR.A
$104B
| $861K | 0.01% |
77,839
-189,729
| -71% | -$1.66M |
|
1013
International Bancshares
IBOC
$4.55B
| $857K | 0.01% |
22,882
-1,290
| -5% | -$40.9K |
|
1014
SiriusXM
SIRI
$9.53B
| $852K | 0.01% |
13,377
-214,770
| -94% | -$13.2M |
|
1015
Caleres
CAL
$462M
| $850K | 0.01% |
54,322
-28,955
| -35% | -$324K |
|
1016
Pennant Group
PNTG
$1.35B
| $844K | 0.01% |
+14,542
| New | +$699K |
|
|
TPTX
1017
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $838K | 0.01% |
6,878
-52,481
| -88% | -$5.75M |
|
1018
Moelis & Co
MC
$4.9B
| $832K | 0.01% |
+17,786
| New | +$715K |
|
1019
Silgan Holdings
SLGN
$4.43B
| $825K | 0.01% |
22,242
-25,472
| -53% | -$918K |
|
1020
ArcBest
ARCB
$3.27B
| $821K | 0.01% |
19,233
+4,501
| +31% | +$171K |
|
|
TPIC
1021
DELISTED
TPI Composites
TPIC
| $819K | 0.01% |
15,519
+1,747
| +13% | +$69.8K |
|
|
DNB
1022
DELISTED
Dun & Bradstreet
DNB
| $816K | 0.01% |
+32,759
| New | +$874K |
|
|
PRO
1023
DELISTED
PROS Holdings
PRO
| $814K | 0.01% |
16,030
-1,642
| -9% | -$64.9K |
|
1024
Patterson-UTI
PTEN
$4.17B
| $813K | 0.01% |
154,613
-68,119
| -31% | -$268K |
|
|
SPNS
1025
DELISTED
Sapiens International
SPNS
| $813K | 0.01% |
+26,550
| New | +$778K |
|
Similar funds
VAI
JG
Voloridge Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, Voloridge Investment Management held 1,692 positions worth $11.9B, down 0.84% from $12B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Voloridge Investment Management withdrew a net $1.72B in Q4 2020, closing 413 positions and reducing 482 holdings. Its most notable exit was Wells Fargo, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in AstraZeneca worth $154M.
- Voloridge Investment Management's largest Q4 2020 buy was AstraZeneca: 1,542,881 shares worth $154M.
- Voloridge Investment Management added most to Microsoft in Q4 2020, an estimated $242M increase.
- Voloridge Investment Management's biggest Q4 2020 reduction was Citigroup, cutting an estimated $234M.
- Voloridge Investment Management fully exited Wells Fargo in Q4 2020, selling an estimated $111M.
- Voloridge Investment Management's ten largest holdings make up 17% of its $11.9B portfolio in Q4 2020.
- Voloridge Investment Management opened 482 new positions and closed 413 in Q4 2020.
- Voloridge Investment Management's portfolio value fell 0.84% quarter-over-quarter to $11.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.